Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and observe the pharmacokinetics
(distribution and elimination of the drug) of the compound dexanabinol (ETS2101) in healthy
male subjects following a single oral dose.